Aura Drugs And Intermediates Private Limited

Pharmaceutical trading company incorporated in 2021, based in Ahmedabad, Gujarat.

2021 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Aura Drugs And Intermediates Profile

Key Indicators

  • Authorised Capital ₹ 3.50 Cr
  • Paid Up Capital ₹ 3.50 Cr
  • Company Age 4 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 13.90 Cr
  • Revenue Growth %
  • Net Worth -177.53%
  • Total Assets 81.84%

About Aura Drugs And Intermediates

Aura Drugs And Intermediates Private Limited (ADAIPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2021 (Four years and one month 21 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.50 Cr.

The company currently has active open charges totaling ₹13.90 Cr.

Jaykumar Joshi, Dhaval Vankani, Abha Vankani, and Two other members serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24299GJ2021PTC121215

  • Company No.

    121215

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Mar 2021

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma
Company report

Aura Drugs And Intermediates Private Limited

Explore comprehensive data for Aura Drugs And Intermediates Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Aura Drugs And Intermediates?

Board Members (5)

NameDesignationAppointment DateStatus
Dhaval Vankani Country flag representing In Director 16-Mar-2021Current
Jaykumar Joshi Country flag representing In Director 16-Mar-2021Current
Abha Vankani Country flag representing In Director 16-Mar-2021Current
Nileshkumar Chaudhari Country flag representing In Director 16-Mar-2021Current
Vimladevi Shah Director 10-Jul-2023Current

Financial Performance of Aura Drugs And Intermediates.

Aura Drugs And Intermediates Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 177.53%.

Aura Drugs And Intermediates revenue growth over time
Aura Drugs And Intermediates profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
81.84%
Profit or Loss
Net Worth
-177.53%
EBITDA

What is the Ownership and Shareholding Structure of Aura Drugs And Intermediates?

Unlock access to Aura Drugs And Intermediates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹13.90 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 13.90 Cr

Latest Charge Details

DateLenderAmountStatus
06 Mar 2024Others₹6.95 CrOpen
06 Mar 2024Others₹6.95 CrOpen

How Many Employees Work at Aura Drugs And Intermediates?

Aura Drugs And Intermediates has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Aura Drugs And Intermediates Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aura Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aura Drugs And Intermediates's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Aura Drugs And Intermediates

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 6.95 Cr with Charge ID 100889087 was registered on 06 Mar 2024.

  • Charges

    A charge with Others amounted to Rs. 6.95 Cr with Charge ID 100889091 was registered on 06 Mar 2024.

  • Annual General Meeting

    Aura Drugs And Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Director Appointment

    Vimladevi Nimeshkumar Shah was appointed as a Director was appointed as a Director on 10 Jul 2023 & has been associated with this company since 1 year 9 months .

  • Balance Sheet

    Aura Drugs And Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.

  • Director Appointment

    Jaykumar Rajnikant Joshi was appointed as a Director was appointed as a Director on 16 Mar 2021 & has been associated with this company since 4 years 1 month .

Frequently asked questions

  • What is the Incorporation or founding date of Aura Drugs And Intermediates Private Limited?

    Aura Drugs And Intermediates Private Limited was incorporated on 16 Mar 2021.

  • What is authorized share capital and paid-up capital of Aura Drugs And Intermediates Private Limited?

    The authorized share capital of Aura Drugs And Intermediates Private Limited is ₹ 3.50 Cr and paid-up capital is ₹ 3.50 Cr.

  • Who are the current board members & directors of Aura Drugs And Intermediates Private Limited?

    Currently 5 directors are associated with Aura Drugs And Intermediates Private Limited.

    • Jaykumar Rajnikant Joshi
    • Dhaval Champaklal Vankani
    • Abha Dharmendra Vankani
    • Nileshkumar Laxmanbhai Chaudhari
    • Vimladevi Nimeshkumar Shah
  • What is the registered address of Aura Drugs And Intermediates Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Aura Drugs And Intermediates Private Limited is F-103 Swaminarayan Avenue Nr. Naranpura Aec Office, India, Ahmedabad, Gujarat, 380013.

  • What is the corporate identification number (CIN) and company number of Aura Drugs And Intermediates Private Limited?

    The corporate identification number (CIN) of Aura Drugs And Intermediates Private Limited is U24299GJ2021PTC121215 and the company number is 121215 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Aura Drugs And Intermediates Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Aura Drugs And Intermediates Private Limited has experienced an downturn of -177.53%.

  • What are the total open charges for Aura Drugs And Intermediates Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Aura Drugs And Intermediates Private Limited amount to ₹ 13.90 Cr.

  • When was the last Balance Sheet of Aura Drugs And Intermediates Private Limited filed with the ROC?

    The most recent Balance Sheet for Aura Drugs And Intermediates Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial